NewEdge Advisors’s Aehr Test Systems AEHR Stock Holding History

NewEdge Advisors’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$448K	Sell	12,082 -722	-6%	-$23.1K	﹤0.01%	2085
2025 Q4	$259K	Sell	12,804 -3,155	-20%	-$76.3K	﹤0.01%	2415
2025 Q3	$481K	Buy	15,959 +15,914	+35,364%	+$345K	﹤0.01%	1846
2025 Q2	$582	Hold	45	–	–	﹤0.01%	3786
2025 Q1	$328	Sell	45 -100	-69%	-$1.11K	﹤0.01%	3761
2024 Q4	$2.41K	Hold	145	–	–	﹤0.01%	3413
2024 Q3	$1.86K	Sell	145 -540	-79%	-$7.81K	﹤0.01%	3395
2024 Q2	$7.65K	Sell	685 -400	-37%	-$4.66K	﹤0.01%	2950
2024 Q1	$13.5K	Sell	1,085 -19,482	-95%	-$325K	﹤0.01%	2770
2023 Q4	$546K	Buy	20,567 +5,957	+41%	+$174K	0.01%	1237
2023 Q3	$668K	Buy	14,610 +9,225	+171%	+$428K	0.01%	1049
2023 Q2	$222K	Buy	5,385 +1,455	+37%	+$47.7K	﹤0.01%	1591
2023 Q1	$122K	Sell	3,930 -3,908	-50%	-$126K	﹤0.01%	1689
2022 Q4	$8.09K	Buy	+7,838	New	+$168K	﹤0.01%	2437

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors's AEHR Position: Q1 2026 in Review

NewEdge Advisors reduced its Aehr Test Systems (AEHR) stake by 5.6% in Q1 2026, selling an estimated $23.1K and leaving 12,082 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #2085.

NewEdge Advisors first reported a position in AEHR in Q4 2022 and has held it in 14 quarters since. The position peaked at $668K in Q3 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

NewEdge Advisors held 12,082 shares of Aehr Test Systems worth $448K as of Q1 2026.
NewEdge Advisors sold 722 Aehr Test Systems shares in Q1 2026, an estimated $23.1K.
Aehr Test Systems made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2085 holding.
NewEdge Advisors first reported a position in Aehr Test Systems in Q4 2022 and has held it in 14 quarters since.
NewEdge Advisors's Aehr Test Systems position peaked at $668K in Q3 2023.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.